Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -23.58%11.15M | 3.42%11.4M | 35.97%11.31M | -2.71%47.88M | 45.65%13.96M | 7.64%14.59M | -22.33%11.02M | 8.32M | 9.32%49.22M | 9.58M |
| Cost of revenue | -22.96%5.1M | 16.24%5.26M | 59.96%5.46M | -6.20%20.44M | 39.45%5.89M | 19.96%6.62M | -27.05%4.53M | 3.41M | 18.31%21.8M | 4.23M |
| Gross profit | -24.10%6.05M | -5.51%6.14M | 19.26%5.85M | 0.07%27.44M | 50.54%8.06M | -0.82%7.97M | -18.67%6.5M | 4.9M | 3.09%27.42M | 5.36M |
| Operating expense | -8.82%4.19M | -19.44%4.38M | -0.04%4.63M | 4.35%19.58M | -25.26%4.92M | 15.64%4.59M | 59.75%5.44M | 4.63M | 55.63%18.76M | 6.58M |
| Selling and administrative expenses | -7.12%4.49M | -17.49%4.66M | -6.05%4.95M | 5.02%21.62M | -20.35%5.95M | 13.73%4.83M | 46.32%5.64M | --5.27M | 27.38%20.59M | --7.47M |
| -Selling and marketing expense | 17.36%568K | -17.26%580K | 10.33%534K | -10.87%2.23M | 8.84%554K | -30.46%484K | -11.38%701K | --484K | 20.17%2.5M | --509K |
| -General and administrative expense | -9.85%3.92M | -17.53%4.08M | -7.71%4.42M | 7.21%19.39M | -22.49%5.4M | 22.39%4.35M | 61.21%4.94M | --4.79M | 28.45%18.09M | --6.96M |
| Total other operating income | 25.74%298K | 34.31%274K | -49.61%322K | 11.88%2.04M | 15.96%1.03M | -13.82%237K | -54.87%204K | --639K | -55.54%1.83M | --890K |
| Operating profit | -44.85%1.86M | 66.01%1.76M | 349.08%1.22M | -9.21%7.86M | 356.15%3.14M | -16.89%3.38M | -76.90%1.06M | 271K | -40.46%8.66M | -1.23M |
| Net non-operating interest income (expenses) | 50.00%-50K | 18.27%-85K | 48.44%-99K | 52.71%-491.07K | -255.74%-95K | 75.49%-100K | 72.56%-104K | -192K | -1.59%-1.04M | 61K |
| Non-operating interest income | 8.82%148K | -18.42%124K | -18.12%122K | 140.33%569.4K | -16.46%132K | 518.18%136K | 442.86%152K | --149K | 212.23%236.93K | --158K |
| Non-operating interest expense | -16.10%198K | -18.36%209K | -35.19%221K | -16.85%1.06M | 134.02%227K | -45.12%236K | -37.10%256K | --341K | 16.14%1.28M | --97K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -148.95%-6.61K | 89.92%-2.66K | ||||||||
| Less:Write off | ---- | ---- | ---- | 148.95%6.61K | ---- | ---- | ---- | ---- | -89.92%2.66K | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -44.70%1.81M | 75.18%1.67M | 1,315.19%1.12M | -3.34%7.36M | 361.41%3.05M | -10.36%3.28M | -77.29%955K | 79K | -43.55%7.62M | -1.17M |
| Income tax | -67.09%386K | 3.04%441K | 1,730.00%366K | -30.18%2.29M | -32.33%609K | -10.18%1.17M | -52.39%428K | 20K | 11.35%3.28M | 900K |
| Net income | -32.23%1.43M | 133.78%1.23M | 1,174.58%752K | 16.94%5.07M | 218.05%2.44M | -10.45%2.11M | -84.06%527K | 59K | -58.87%4.34M | -2.07M |
| Net income continuous operations | -32.23%1.43M | 133.78%1.23M | 1,174.58%752K | 16.94%5.07M | 218.05%2.44M | -10.45%2.11M | -84.06%527K | --59K | -58.87%4.34M | ---2.07M |
| Noncontrolling interests | -8.49%97K | 29.73%-52K | -45.45%24K | -83.58%39.3K | -165.45%-36K | -23.74%106K | -1,750.00%-74K | 44K | -2.27%239.35K | 55K |
| Net income attributable to the company | -33.48%1.33M | 113.64%1.28M | 4,753.33%728K | 22.81%5.03M | 216.69%2.48M | -9.62%2M | -81.84%601K | 15K | -60.22%4.1M | -2.12M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -33.48%1.33M | 113.64%1.28M | 4,753.33%728K | 22.81%5.03M | 216.69%2.48M | -9.62%2M | -81.84%601K | 15K | -60.22%4.1M | -2.12M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -33.33%0.004 | 100.00%0.004 | 4,661.90%0.002 | -54.40%0.014 | 216.67%0.007 | -2.44%0.006 | -78.25%0.002 | 0 | 7.26%0.0307 | -0.006 |
| Diluted earnings per share | -33.33%0.004 | 100.00%0.004 | 4,661.90%0.002 | -54.40%0.014 | 216.67%0.007 | -2.44%0.006 | -78.25%0.002 | 0 | 7.26%0.0307 | -0.006 |
| Dividend per share | 0 | 0 | 0.0025 | 0.005 | 0 | 0 | 0.005 | |||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.